This is a specific inherited type of hyperlipoproteinemia. It happens because your body doesn't break down certain fats properly. This can lead to high levels of triglycerides in your blood.
Every report comes from a Lived member, sent anonymously.
Have you tried Low-Fat Diet for Familial Chylomicronemia Syndrome?
Familial chylomicronemia syndrome (FCS) is a rare inherited disorder in which the body cannot properly clear fat from the blood. Fat from food travels through the bloodstream in large particles called chylomicrons, which carry triglycerides, the main type of fat in food and in the blood. Normally an enzyme called lipoprotein lipase breaks these particles down. In FCS, that enzyme or a protein it depends on works very poorly or not at all, so chylomicrons build up and triglyceride levels stay extremely high, often many times the normal level. The most serious consequence is acute pancreatitis, a sudden, painful inflammation of the pancreas that usually needs hospital care and can be life-threatening. Most people with FCS have had at least one episode, and about half have repeated episodes. Between attacks, many people live with recurring abdominal pain, bloating, fatigue and difficulty concentrating. Other signs include clusters of small yellow bumps of fat in the skin (eruptive xanthomas) and blood that looks milky when it is drawn. FCS is different from the far more common causes of very high triglycerides, which usually combine an inherited tendency with factors such as diabetes, alcohol or certain medicines (a pattern called multifactorial chylomicronemia). The two can look alike on a blood test, but their causes and treatment differ. Hyperlipoproteinemia type I and familial lipoprotein lipase deficiency are older names for this condition.
FCS is caused by changes (variants) in genes that the fat-clearing enzyme needs. Depending on the population, 50 to 90 percent of people with FCS have variants in both copies of the LPL gene, which makes lipoprotein lipase itself. The rest have variants in both copies of one of four genes for proteins that help the enzyme work: APOC2, APOA5, GPIHBP1 or LMF1. Because a person has to inherit an altered copy from each parent, FCS often appears in a family with no known history of it. Parents who carry a single copy usually do not have FCS. FCS affects roughly 1 to 10 people per million and is thought to be underdiagnosed. It is much more common in certain areas of Quebec, Canada. The genetic cause is always present, but some things push triglycerides higher and make pancreatitis more likely: fat in the diet, simple sugars and other refined carbohydrates, and alcohol. Pregnancy is a particularly high-risk time because triglycerides naturally rise. Some medicines, uncontrolled diabetes and an underactive thyroid can raise triglycerides further.
Diagnosis starts with a blood test for triglycerides, measured in milligrams per deciliter (mg/dL). A normal level is below 150 mg/dL. In FCS, fasting triglycerides are typically 880 mg/dL or higher, and often in the thousands, on repeated tests. The blood sample may look milky, and after standing in a refrigerator a creamy layer of chylomicrons can form on top. A very high triglyceride result alone does not mean FCS, because the multifactorial form is far more common. Specialists look at the whole picture: symptoms beginning in childhood, adolescence or young adulthood; a history of pancreatitis or unexplained recurring abdominal pain; no secondary cause such as uncontrolled diabetes or heavy drinking; little response to standard triglyceride medicines; and triglycerides far out of proportion to total cholesterol. Validated scoring tools combine these features to judge how likely FCS is. Genetic testing of the five known genes confirms the diagnosis when it finds variants in both copies of one of them. About a quarter of people with a typical clinical picture have a negative genetic test. In that case, some specialized laboratories can measure lipoprotein lipase activity directly. An eye exam may show pale, creamy-looking blood vessels in the retina (lipemia retinalis), which does not affect vision.
There is no cure for FCS. Treatment aims to keep triglycerides low enough to prevent pancreatitis and ease day-to-day symptoms. The foundation, for everyone and for life, is a very low-fat diet: generally less than 15 to 20 grams of fat a day, which is under 15 percent of daily calories. That is far stricter than typical low-fat or heart-healthy eating, and standard low-fat or diabetes recipes are often still too high in fat. Alcohol and simple sugars are limited too. A registered dietitian experienced with FCS is a central part of care. Because the diet contains so little fat, vitamins A, D, E and K, which need fat to be absorbed, may need monitoring and supplements. Medium-chain triglyceride (MCT) oil, a processed fat that is absorbed without forming chylomicrons, can add calories and make food easier to prepare, though it can be expensive. Standard triglyceride medicines, such as statins, fibrates and omega-3 fatty acid (fish oil) prescriptions, usually help little in FCS because they rely on the clearance pathway that is not working. Two newer medicines work differently. Olezarsen (Tryngolza) and plozasiran (Redemplo) reduce the liver's production of apolipoprotein C-III, a protein that slows triglyceride clearance, and appear to help the liver remove fat-carrying particles by a route that does not depend on lipoprotein lipase. Both are approved in the United States for adults with FCS as an addition to the diet, not a replacement for it. Olezarsen is injected under the skin once a month, and plozasiran every three months; people or caregivers are trained to give the injections at home. In their main trials, triglycerides fell substantially more than with placebo, by 43 percent more at six months with olezarsen and 59 percent more at ten months with plozasiran. Fewer people on either medicine had pancreatitis during the year of treatment, though the trials were small and pancreatitis was not their main measure. Neither medicine corrects the underlying cause. Trade-offs to discuss include injection-site reactions with both; allergic reactions, rises in liver enzymes and lower platelet counts with olezarsen; and higher blood sugar with plozasiran. An attack of pancreatitis is treated in the hospital with fluids through a vein, a period without eating, pain control and close monitoring, followed by a gradual return to very low-fat food.
FCS is lifelong. For most people the biggest daily demand is the diet: counting grams of fat, reading labels, planning ahead for restaurants, travel and social events, and finding enough food that is both satisfying and safe. Many people also live with recurring abdominal discomfort, fatigue or brain fog, and with worry about the next attack of pancreatitis. Skin xanthomas and milky blood tend to clear when fat intake and triglyceride levels come down. The course varies widely. Some people have few symptoms, while others have repeated pancreatitis. Repeated attacks can permanently damage the pancreas, leading to chronic pancreatitis and to diabetes caused by loss of insulin-producing cells (sometimes called type 3c diabetes). When diabetes develops, its eating plan needs adjusting, because many standard diabetes diets contain too much fat for FCS. Care is usually shared between a lipid specialist (lipidologist) or endocrinologist and a dietitian, with regular triglyceride checks, vitamin monitoring and, for people taking the newer medicines, follow-up blood tests. Pregnancy needs planning with a team that includes obstetric care: in one study, 42 percent of women with FCS had pancreatitis during at least one pregnancy, and close multidisciplinary monitoring was linked to far fewer episodes. Pancreatitis caused by FCS is sometimes mistaken by hospital teams unfamiliar with the condition for alcohol-related disease, or long-standing abdominal pain is not taken seriously. Telling staff about the diagnosis, and asking them to contact the FCS specialist, can help.
Ask about an evaluation for FCS if triglycerides have measured around 880 mg/dL or higher more than once, especially when this began at a young age, came with pancreatitis that had no clear cause, or did not improve with standard treatment. Contact your care team if you are planning a pregnancy or become pregnant, if triglycerides rise despite following the diet, if belly pain or bloating becomes more frequent, or before starting a new medicine that might raise triglycerides. Go to an emergency department right away for symptoms of acute pancreatitis: pain in the upper abdomen that is severe or getting worse, often spreading to the back, or abdominal pain with vomiting, fever or chills, a fast heartbeat, shortness of breath or yellowing of the skin or eyes.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Familial Chylomicronemia Syndrome is like, what's helped you, or ask the community a question.